Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Zhenglin Ou

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5073742168. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: 4 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 8

  1. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells. Co-author DOI 10.3389/fimmu.2023.1271603↗
  2. Comparisons of Outcomes Between Adolescent and Young Adult with Older Patients After Radical Resection of Pancreatic Ductal Adenocarcinoma by Propensity Score … Co-author DOI 10.2147/cmar.s337687↗
  3. [Current consensus and controversy in neoadjuvant therapy for pancreatic cancer]. Co-author DOI 10.3760/cma.j.issn.0529-5815.2020.02.005↗
  4. RELA/NEAT1/miR-302a-3p/RELA feedback loop modulates pancreatic ductal adenocarcinoma cell proliferation and migration. Co-author DOI 10.1002/jcp.27039↗
  5. Long noncoding RNA FEZF1-AS1 predicts poor prognosis and modulates pancreatic cancer cell proliferation and invasion through miR-142/HIF-1α and miR-133a/EGFR u… Co-author DOI 10.1002/jcp.28188↗
  6. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis. Co-author DOI 10.1080/15476286.2019.1649585↗
  7. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. Co-author DOI 10.3748/wjg.v25.i46.6728↗
  8. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn. Co-author DOI 10.1016/j.biopha.2018.06.114↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yebin Lu · 4 shared papers, 2019–2023 · strength 0.65
  2. Zhen Luo · 4 shared papers, 2019 · strength 0.48
  3. Yixiong Li · 3 shared papers, 2018–2020 · strength 0.37
  4. Zhen Luo · 1 shared paper, 2023 · strength 0.26
  5. Mujing Ke · 2 shared papers, 2018–2020 · strength 0.26
  6. Neng Tang · 2 shared papers, 2018–2021 · strength 0.26
  7. Guodong Liu · 2 shared papers, 2018–2021 · strength 0.26
  8. Tong Han · 2 shared papers, 2019 · strength 0.21
  9. Hongyan Zai · 1 shared paper, 2021 · strength 0.16
  10. Shuai Liang · 1 shared paper, 2019 · strength 0.11
  11. Min Zhang · 1 shared paper, 2019 · strength 0.11
  12. Feizhou Huang · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.